YSB(09885) connects to DeepSeek, pioneering the new blue ocean of grassroots intelligent healthcare.
13/02/2025
GMT Eight
Recently, YSB (09885) announced that its grassroots intelligent medical overall solution "Spectrum Hut" is being integrated with cutting-edge big models such as DeepSeek, committed to promoting the widespread and deep application of AI technology in the field of grassroots medical care, empowering grassroots medical institutions and grassroots doctors comprehensively. YSB's "Spectrum Hut" integrates real-time detection equipment "Future Spectrum" series products, clinic SaaS system "Spectrum Cloud Diagnosis", and AI doctor assistance system "Spectrum Intelligent Doctor", showing initial effectiveness in enhancing the capabilities of grassroots medical services, demonstrating its application potential, and is expected to reshape the landscape of grassroots intelligent medical care.
According to the company's announcement, the "Future Spectrum" series of chronic disease detection devices, mini blood cell counters, and immunodeficiency mini-box have sold over 15,000 units within a few months of their launch, with the monthly testing scale continuously increasing to over 150,000 people. This series of products are applied in scenarios such as rapid disease treatment, chronic disease detection and management, and epidemic monitoring and treatment, realizing "online remote cloud testing" through digital technology, streamlining the diagnostic process, providing precise diagnostic references for doctors, and improving the quality and efficiency of diagnosis and treatment for grassroots patients.
From a market perspective, the grassroots medical market has huge potential. According to data from the National Health Commission, the number of grassroots medical institutions nationwide has exceeded 1 million, and continues to grow steadily. Zhong Kang Technology estimates that by 2030, the market size of grassroots medical care is expected to rapidly increase to 329.4 billion yuan. In addition, national policies continue to promote the sinking of high-quality medical resources, bringing more opportunities for the development of grassroots medical care. It was disclosed that as of the first half of 2024, the number of YSB grassroots medical institution users has exceeded 310,000, making it the largest digital navigator in the field of outpatient grassroots medical care, rapidly seizing this market highland.
In the current outpatient pharmaceutical industry, the market environment is undergoing profound changes, and competition dimensions have fundamentally shifted. The speed of using AI technology to achieve intelligent transformation has become a key factor in determining the success or failure of enterprises. With the dual benefits of strong support from national policies and the continuous growth of grassroots medical care demand, the grassroots intelligent medical market has entered a golden age of explosive growth. Currently, YSB, through deep digitization empowerment, has shown signs of a new growth curve in the vast market of grassroots medical care. Looking ahead, we eagerly anticipate whether YSB can continue to lead the digitization transformation of grassroots medical care with its first-mover advantage in technology application and service mode innovation.